Rhumbline Advisers Dyadic International Inc Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.35 - $5.67 $53,924 - $91,269	-16,097 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$5.35 - $7.77 $9,977 - $14,491	1,865 Added 13.1%	16,097 $87,000
Q3 2020 Nov 12, 2020	SELL	$7.22 - $9.11 $19,927 - $25,143	-2,760 Reduced 16.24%	14,232 $108,000
Q2 2020 Aug 13, 2020	BUY	$4.93 - $10.26 $83,770 - $174,337	16,992 New	16,992 $147,000

4.77M

20.6K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $51.7M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.